Amag Pharmaceuticals Inc is categorized under In Vitro Diagnostics in Waltham, MA and active since 1981.
Amag Pharmaceuticals Inc was established in 1981, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a In Vitro Diagnostics business, which does work in the B2B market, and is classified as a In Vitro Diagnostics, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact William K Heiden at the company’s single location by writing to 1100 Winter St, Waltham, Massachusetts MA 02451 or by phoning (781) 466-9521. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amag Pharmaceuticals Inc |
| Contact Person: | William K Heiden |
| Address: | 1100 Winter St, Waltham, Massachusetts 02451 |
| Phone Number: | (781) 466-9521 |
| Website Address: | amagpharma.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | In Vitro Diagnostics |
| SIC Code: | 2835 |
| NAICS Code: | 4242101 |
| Share This Business: |
Amag Pharmaceuticals Inc was started in 1981 to provide professional In Vitro Diagnostics under the SIC code 2835 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact William K Heiden for inquiries that concern Amag Pharmaceuticals Inc by calling the company number (781) 466-9521, as your correspondence is most welcome. Additionally, the physical location of the single location of Amag Pharmaceuticals Inc can be found at the coordinates 42.40978,-71.2734 as well as the street address 1100 Winter St in Waltham, Massachusetts 02451.
For its online presence, you may visit Amag Pharmaceuticals Inc’s website at amagpharma.com and engage with its social media outlets through on Twitter and on Facebook.